Scientific publications

A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis

May 1, 2020 | Magazine: Actas Dermosifiliográficas

J Cañueto  1 , A Tejera-Vaquerizo  2 , P Redondo  3 , R Botella-Estrada  4 , S Puig  5 , O Sanmartin  6


Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer in humans and its incidence is both underestimated and on the rise. cSCC is referred to in the literature as high-risk cSCC, locally advanced cSCC, metastatic cSCC, advanced cSCC, and aggressive cSCC.

These terms can give rise to confusion and are not always well defined. In this review, we aim to clarify the concepts underlying these terms with a view to standardizing the description of this tumor, something we believe is necessary in light of the new drugs that have been approved or are in development for cSCC.

CITATION  Actas Dermosifiliogr (Engl Ed). 2020 May;111(4):281-290. doi: 10.1016/  Epub 2020 Apr 28

Our authors